Non-viral vectors for chimeric antigen receptor immunotherapy
Chimeric antigen receptor (CAR) T cell therapy has demonstrated remarkable efficacy in haematological malignancies. However, although viral vector-…
Category: Immunotherapy
Identification of the conditions and minimum requirements necessary for the release of autologous fresh CAR T-cell products under hospital exemption: a position paper from the WP-bioproduction of the UNITC consortium
The accessibility of CAR-T cells in centralized production models faces significant challenges, primarily stemming from logistical complexities and…